44 - Risk Management in Preclinical Phase (S3E14)

Dive into the essential world of risk management in the preclinical phase of drug development. This episode explores how scientists identify, assess, and mitigate risks before a new drug is even tested in humans. We'll discuss the use of risk matrices and decision frameworks, highlighting their strengths and limitations in visualizing and prioritizing risks. Using real-world case studies, including challenges in developing new delivery systems and absorption issues, we'll demonstrate how proactive risk management can prevent costly setbacks and protect patients.

Furthermore, this episode examines the impact of regulatory guidelines from the FDA and ICH on risk assessment, emphasizing the importance of considering ethical concerns and animal welfare. We'll explore how advancements in technology, such as AI and big data, are transforming pre-clinical risk management, offering new tools for analyzing vast amounts of data and identifying potential hazards early on. Finally, we'll discuss the ethical considerations surrounding the use of these powerful technologies and the ongoing need for human expertise and judgment in drug development. Join us as we uncover the critical role of risk management in ensuring the safety and success of new treatments.